Therefore, the primary objective of this study was to determine the impact of IH on CD36 expression as well as on lipid content in livers from OSA patients with biopsy-proven NAFLD and in livers from mice exposed to IH. The gene discussed is CD36; the disease is metabolic dysfunction-associated steatotic liver disease.